Foghorn Therapeutics

FHTX

4.7000.84% ( -0.040 )

Trading: Jul 30, 12:07:17 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Foghorn Therapeutics(FHTX) predict that the Revenue is 3.267 M (-45.11%), Miss estimate;the EBIT is -21.57 M (+5.85%), Beat estimate;the EPS is -0.29 (+3.33%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B45.11%

0.01B33.47%

-0.00B78.58%

EBITExceed expectations

-0.02B5.85%

-0.02B0.35%

+0.00B5.50%

EPSExceed expectations

-0.293.33%

-0.3051.67%

+0.01505.00%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD